QA: Acer Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2021_Acer_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001069308, Acer Therapeutics Inc

  xvar xval
0 AssetsCurrent 6,441,029
1 IntangibleAssetsNetIncludingGoodwill 7,647,267
2 PropertyPlantAndEquipmentNet 130,081
3 remainder_Assets 395,311
4 LiabilitiesCurrent 6,145,546
5 LiabilitiesNoncurrent 243,808
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,185,258
9 ResearchAndDevelopmentExpense 12,101,004
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -66,029
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,613,688
1 Liabilities 6,389,354
2 Expenses 24,286,262
3 Revenues 0
4 StockholdersEquity 8,224,334
5 NetIncome -24,352,291
6 ComprehensiveNetIncome -24,352,291
7 BaseVar 22,677,666
8 EconomicCapitalRatiobeforeLimitedLiability -0.612
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time